
iwAL 2023 Session IV: Transplantation and immunotherapies in AML: improving patient outcomes
VJHemOnc Podcast
00:00
Designing a Randomized Study and Lessons from Morpho Data in Transplantation and Immunotherapies for AML
This chapter explores the design of a randomized study led by Dr. Victoria Potter, called ProDLI, which evaluates prophylactic DLI in high-risk AML patients. It also discusses the importance of using asyls judiciously with certain drugs and provides an update on morpho data.
Play episode from 11:53
Transcript


